Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,115.70
-7.3000-0.65%
Pre-market: 1,122.506.80+0.61%04:22 EDT
Volume:1.84M
Turnover:2.06B
Market Cap:1.05T
PE:37.45
High:1,131.44
Open:1,129.41
Low:1,113.29
Close:1,123.00
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.82
T/O Rate:0.20%
Dividend:6.69
Dividend Rate:0.60%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:31.13
PE(LYR):48.61

Loading ...

Rothschild & Co Redburn Adjusts Eli Lilly and Co. PT to $915 From $900, Keeps Neutral Rating

MT Newswires Live
·
Aug 12

Why This Growth Stock Manager Likes Both the AI Trade and Eli Lilly

Morning Star
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Eli Lilly's Foundayo Gains First European Approval, Igniting Global Oral Weight-Loss Drug Battle

Deep News
·
Aug 11

What Does Eli Lilly (LLY) Gain From Its Oncology Push And New Funding Bet?

Simply Wall St.
·
Aug 11

MHRA authorizes Eli Lilly’s weight loss pill Foundayo in UK

TIPRANKS
·
Aug 11

Eli Lilly and Co Stock (LLY) Moved Up by 3.48% on Aug 10: Drivers Behind the Movement

TradingKey
·
Aug 11

Movement Alert|Eli Lilly Rises 3.02% in Regular Trading, Oral GLP-1 Drug Gains First European Approval in UK

Market Focus
·
Aug 11

Eli Lilly Rises After UK Regulator Approves Weight-Loss Drug

Reuters
·
Aug 11

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

UK Green Lights Lilly's Obesity Pill

Reuters
·
Aug 10

UK’s MHRA Authorises Orforglipron for Weight Management and Type 2 Diabetes

Reuters
·
Aug 10

Analysts Conflicted on These Healthcare Names: Evolent Health (EVH), Eli Lilly & Co (LLY) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 10

Nvidia, Eli Lilly, and Disney Show It's Time to Back the Top Dogs

Dow Jones
·
Aug 10

Eli Lilly and Company Just Beat Revenue By 11%: Here's What Analysts Think Will Happen Next

Simply Wall St.
·
Aug 08

Form 144 | ELI LILLY Officer Hakim proposes to sell 10000 Shares, with a total value of approximately $11.9 Million.

Filings Track
·
Aug 07

Mediar Therapeutics Signs Collaboration, Option Deal with Ono Pharma on Fibro-Inflammatory Disease Antibodies

Reuters
·
Aug 07

Eli Lilly : Truist Securities Raises Target Price to $1376 from $1370

THOMSON REUTERS
·
Aug 07

Morning BID Americas-Dealjà Vu

Reuters
·
Aug 07

Truist Adjusts Price Target on Eli Lilly & Co. to $1,376 From $1,370, Maintains Buy Rating

MT Newswires Live
·
Aug 07